Study of Mental Care in Spain

Four Dimensions in Schizophrenia

NCT00782899 ·Status: COMPLETED

Assessment of Schizophrenia Patients' Clinical Study Experiences

NCT05948111 ·Status: NOT_YET_RECRUITING

A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthly

NCT03809325 ·Status: COMPLETED

Quality of Life in Schizophrenic Patients

NCT00597168 ·Status: COMPLETED

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.

NCT05958875 ·Status: RECRUITING ·Phase: PHASE4

Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia

NCT00749970 ·Status: COMPLETED

Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

NCT00873249 ·Status: COMPLETED

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

NCT01160679 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Clozapine in Patients With Treatment-resistant Schizophrenia

NCT00250575 ·Status: COMPLETED ·Phase: PHASE3

Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders

NCT03649581 ·Status: RECRUITING ·Phase: NA

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

NCT02874560 ·Status: COMPLETED

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

NCT00528905 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Cognition Study of Sertindole in Patients With Schizophrenia

NCT00759421 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia

NCT03356639 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia

NCT07084831 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

NCT00833456 ·Status: COMPLETED

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals

NCT02220504 ·Status: COMPLETED ·Phase: NA

Sertindole in Asian Patients With Schizophrenia

NCT00864045 ·Status: COMPLETED ·Phase: PHASE3

Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia

NCT00763438 ·Status: COMPLETED ·Phase: PHASE4

Prevalence of Dissociative Disorders in Children

NCT01512641 ·Status: COMPLETED ·Phase: NA

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

NCT02832037 ·Status: COMPLETED ·Phase: PHASE2

A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia

NCT01626885 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of the Safety, PK, and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia

NCT04510298 ·Status: COMPLETED ·Phase: PHASE1

Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder

NCT01769014 ·Status: UNKNOWN

Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting

NCT00932529 ·Status: COMPLETED ·Phase: PHASE4